Connect
MJA
MJA

Pharmaceutical preparations

Editorials

Cancer nanomedicine: challenges and opportunities

Zdenka Kuncic

Med J Aust 2015; 203 (5): 204-205 Free

News / From NPS MedicineWise

Five reasons to not prescribe opioids

Lynn M Weekes

Med J Aust 2015; 203 (5): 206 Free

Perspectives

Precision medicine: are we there?

Ingrid Winship

Med J Aust 2015; 203 (3): 132-133

Clinical focus

A new era in the treatment of multiple sclerosis

Simon A Broadley, Michael H Barnett, Mike Boggild, Bruce J Brew, Helmut Butzkueven, Robert Heard, Suzanne Hodgkinson, Allan G Kermode, Jeannette Lechner-Scott, Richard AL Macdonell, Mark Marriott, Deborah F Mason, John Parratt, Stephen W Reddel, Cameron P Shaw, Mark Slee, Judith M Spies, Bruce V Taylor, William M Carroll, Trevor J Kilpatrick, John King, Pamela A McCombe, John D Pollard and Ernest Willoughby

Med J Aust 2015; 203 (3): 139-141 Free

Case reports / Lessons from practice

Febuxostat-associated rhabdomyolysis in chronic renal failure

Debasish Ghosh, Philippa M McGann, Timothy J Furlong and Richard O Day

Med J Aust 2015; 203 (2): 107-108 Free

Perspectives

State-based legal requirements for Schedule 8 prescriptions: why so complicated?

Andy C Hua, Finna Shen and Xiaoting Ge

Med J Aust 2015; 203 (2): 64-66 Free

Letters

Toxic epidermal necrolysis — an investigation to dye for?

Lloyd J Ridley and Sandhya Limaye

Med J Aust 2015; 203 (2): 76-78

Letters

Knowing when to stop antibiotic therapy

Angus J Thompson, Ivan Bindoff and Andrew C Stafford

Med J Aust 2015; 202 (11): 570

Research

The crux of the matter: Did the ABC's Catalyst program change statin use in Australia?

Andrea L Schaffer, Nicholas A Buckley, Timothy A Dobbins, Emily Banks and Sallie-Anne Pearson

Med J Aust 2015; 202 (11): 591-594 Free

Case reports / Lessons from practice

Warfarin-induced skin necrosis following recommencement of warfarin after perioperative Prothrombinex-VF

Ryan M O’Dempsey, Andrew MTL Choong, Amit Patel, Jason Miller, Philip J Walker and Allan Kruger

Med J Aust 2015; 202 (9): 499-500 Free

Case reports / Snapshot

The trumpet's blown pupil

Chris Plummer and Adam Dangoor

Med J Aust 2015; 202 (9): 497 Free

News / From NPS MedicineWise

Proton pump inhibitors: too much of a good thing?

Lynn M Weekes

Med J Aust 2015; 202 (9): 464 Free

Research

A prospective cohort study of trends in self-poisoning, Newcastle, Australia, 1987–2012: plus ça change, plus c’est la même chose

Nicholas A Buckley, Ian M Whyte, Andrew H Dawson and Geoffrey K Isbister

Med J Aust 2015; 202 (8): 438-442 Free

Research

Polypharmacy among inpatients aged 70 years or older in Australia

Ruth E Hubbard, Nancye M Peel, Ian A Scott, Jennifer H Martin, Alesha Smith, Peter I Pillans, Arjun Poudel and Leonard C Gray

Med J Aust 2015; 202 (7): 373-377 Free

Case reports

First use of creatine hydrochloride in premanifest Huntington disease

Chris Tuckfield

Med J Aust 2015; 202 (7): 378-380 Free

Case reports

Intravenous OxyContin-associated thrombotic microangiopathy treated successfully without plasma exchange

Courtney Tate and Peter Mollee

Med J Aust 2015; 202 (6): 330-331 Free

Editorials

New and emerging treatments for Parkinson disease

Victor S C Fung

Med J Aust 2015; 202 (6): 283-284 Free

Letters

Stable post-TRUS biopsy sepsis rates and antibiotic resistance over 5 years in patients from Newcastle, New South Wales

George Mirmilstein and John Ferguson

Med J Aust 2015; 202 (5): 237

Letters

First do no harm: a real need to deprescribe in older patients

Lisa Kouladjian, Timothy F Chen and Sarah N Hilmer

Med J Aust 2015; 202 (4): 178-179

Letters

Antibiotic prescribing practice in residential aged care facilities — health care providers' perspectives

Ching Jou Lim, Megan W-L Kwong and David C M Kong

Med J Aust 2015; 202 (4): 180

For debate

Costs to Australian taxpayers of pharmaceutical monopolies and proposals to extend them in the Trans-Pacific Partnership Agreement

Deborah H Gleeson, Hazel Moir and Ruth Lopert

Med J Aust 2015; 202 (6): 306-308 Free

Perspectives

Knowing when to stop antibiotic therapy

Gwendolyn L Gilbert

Med J Aust 2015; 202 (3): 121-122 Free

Letters

The effect of fasting diets on medication management

Gina McLachlan and The-Phung To

Med J Aust 2015; 202 (3): 131-132

Case reports / Lessons from practice

Infliximab therapy in two cases of severe neurotuberculosis paradoxical reaction

James S Molton, Paul J Huggan and Sophia Archuleta

Med J Aust 2015; 202 (3): 156-157 Free

Research

An economic case for a cardiovascular polypill? A cost analysis of the Kanyini GAP trial

Tracey-Lea Laba, Alison Hayes, Serigne Lo, David P Peiris, Tim Usherwood, Graham S Hillis, Natasha Rafter, Christopher M Reid, Andrew M Tonkin, Ruth Webster, Bruce C Neal, Alan Cass, Anushka Patel, Anthony Rodgers and Stephen Jan

Med J Aust 2014; 201 (11): 671-673 Free